Naloxegol Oxalate
Records for this ingredient, by country (identity only).
ATC A06AH03 · 4 markets · 9 records
AU 2 records · 2 shown of 2
- 28.5 mgtabletMOVANTIK naloxegol (as oxalate) 25 mg film-coated tablet blister pack
- 14.2 mgtabletMOVANTIK naloxegol (as oxalate) 25 mg film-coated tablet blister pack
FR 2 records · 2 shown of 2
- 28.5 mgtabletMOVENTIG 12,5 mg, comprimé pelliculé
- 14.2 mgtabletMOVENTIG 12,5 mg, comprimé pelliculé
| Strength / form / release | US | CA | AU | FR |
|---|---|---|---|---|
| 28.5 mg tablet | MOVANTIK naloxegol (as oxalate) 25 mg film-coated tablet blister pack | MOVENTIG 12,5 mg, comprimé pelliculé | ||
| 25 mg tablet | MOVANTIK | MOVANTIK | ||
| 14.2 mg tablet | MOVANTIK naloxegol (as oxalate) 25 mg film-coated tablet blister pack | MOVENTIG 12,5 mg, comprimé pelliculé | ||
| 12.5 mg tablet | MOVANTIK | MOVANTIK |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.